Financhill
Back

Intellia Therapeutics Vs. TransMedics Group Industry Stock Comparison

Sell
24

NTLA
Intellia Therapeutics

Last Price:
21.29
Seasonality Move:
34.01%
Buy
67

TMDX
TransMedics Group

Last Price:
88.67
Seasonality Move:
17.51%
Sell
24
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $21.53. The Score for NTLA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
TransMedics Group (TMDX) is a Buy

Is TransMedics Group a Buy, Sell or Hold?

  • The current TransMedics Group [TMDX] share price is $90.53. The Score for TMDX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • TMDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $21.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

TMDX Stock Price Chart

What is TransMedics Group's stock price today?

  • The TransMedics Group share price today is $90.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 29.73 Sell
Chaikin Money Flow: -668295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.71 - 27.11) Sell
Bollinger Bands (100): (24.92 - 30.48) Sell

TMDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.43 Buy
Relative Strength Index (14 RSI): 58.4 Buy
Chaikin Money Flow: 516292 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.64 - 90.86) Buy
Bollinger Bands (100): (75.57 - 88.03) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.1 Sell
20-day SMA: 24.3 Sell
50-day SMA: 26.97 Sell
200-day SMA: 30.97 Sell
8-day EMA: 22.29 Sell
20-day EMA: 23.94 Sell
50-day EMA: 25.88 Sell
200-day EMA: 30.93 Sell

TMDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.17 Buy
20-day SMA: 84.6 Buy
50-day SMA: 83.14 Buy
200-day SMA: 72.67 Buy
8-day EMA: 88.32 Buy
20-day EMA: 86.02 Buy
50-day EMA: 83.31 Buy
200-day EMA: 75.14 Buy

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.

TransMedics Group Earnings Growth & TMDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.76 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

TransMedics Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):